Pieniazek, M., Winsko-Szczęsnowicz, K., Konieczna, A., Danielewicz, I., Dubianski, R., Świderska, K., Żubrowska, J., Gorniak, A., Wronowicz, J., Czartoryska-Arlukowicz, B., Jarzab, M., Łacko, A., Pacholczak-Madej, R., Puskulluoglu, M. (2026). Baseline inflammatory indexes and prognosis for progression-free survival in first-line pembrolizumab plus chemotherapy for PD-L1-positive advanced triple-negative breast cancer: A Polish multicenter cohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13108